greeksoup/ stock research
Stock research / United States / GOSS / Documents

Gossamer Bio, Inc. documents

Gossamer Bio (GOSS) annual report: the 10-K filed 17 March 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 16 September 2026; latest 10-Q filed 13 August 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
13 August 2026Results press release, exhibit 99 to the 8-K filed 13 August 2026The releaseEDGAR folder
27 July 2026Results press release, exhibit 99 to the 8-K filed 27 July 2026The releaseEDGAR folder
18 May 2026Results press release, exhibit 99 to the 8-K filed 18 May 2026The releaseEDGAR folder
17 March 2026Results press release, exhibit 99 to the 8-K filed 17 March 2026The releaseEDGAR folder
5 November 2025Results press release, exhibit 99 to the 8-K filed 5 November 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
17 March 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
13 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
15 May 202610-Q, period ended 31 March 2026The documentEDGAR folder
5 November 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
16 September 2026DEF 14A, period ended 27 October 2026The documentEDGAR folder
9 June 2026DEF 14A, period ended 14 July 2026The documentEDGAR folder
24 April 2026DEF 14A, period ended 24 April 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
24 April 2026ARS, period ended 24 April 2026The documentEDGAR folder